SK Bioscience to develop 2nd-generation Ebola vaccine

South Korea's SK Bioscience Co. announced on Wednesday that it signed a business agreement with the international non-profit research organization H...

Dong-A ST, UMass to jointly research for gene therapy

South Korea's Dong-A ST announced on Friday it has signed a joint research agreement with the University of Massachusetts (UMass) Chan Medical Schoo...

SK Bioscience to produce MSD’s new Ebola vaccine candidate

SK Bioscience Co., the drug-making unit of South Korea’s SK Group, announced on Monday that it has signed a contract with MSD, a global pharma...

Celltrion teams up with bio venture to develop new anti-cancer drug

South Korea's biopharmaceutical company Celltrion Inc. will develop an anti-cancer drug that combines oncolytic virus technology with biosimilars un...

Celltrion says COVID-19 antibody kills virus within 5 days; shares surge

South Korea’s biopharmaceutical firm Celltrion Inc. can unveil an antibody treatment by around the end of the year that is able to kill the COVI...

NPS raises virus-induced threat level to grave; runs emergency team

The National Pension Service (NPS) takes the current financial market volatility caused by the COVID-19 outbreak as a grave threat and is operating it...